DOSSIER · 13F Holders · Q4 2025
NVIVDEUR
INVIVO THERAPEUTICS HLDGS CORPORATION
1 institutions still hold INVIVO THERAPEUTICS HLDGS CORPORATION as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 46186M605·1 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
1 institutions reported NVIVDEUR in Q4 2025. Top-holder concentration data is loading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.